Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 14th, 2024 |
NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| November 14th, 2024 |
NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| November 14th, 2024 |
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) |
National Institutes of Health |
| November 15th, 2022 |
NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 22nd, 2022 |
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) |
National Institutes of Health |
| November 30th, 2022 |
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
| November 14th, 2024 |
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| August 22nd, 2022 |
REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 21st, 2022 |
Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 13th, 2027 |
AHRQ Mentored Clinical Scientist Research Career Development Award (K08) |
Agency for Health Care Research and Quality |
| November 21st, 2022 |
TB Free Uzbekistan |
Kazakhstan USAID Almaty |
| November 30th, 2022 |
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 30th, 2022 |
Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 14th, 2024 |
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 6th, 2024 |
HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 4th, 2022 |
Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 6th, 2023 |
Global Emergency Response and Recovery Partner Engagement: Expanding Efforts and Strategies to Improve Rapid Response to Public Health Emergencies Globally |
Centers for Disease Control CGH |
| May 15th, 2023 |
Strengthening Global Capacity for Molecular Surveillance and Outbreak Response for Enteric Diseases |
Centers for Disease Control NCEZID |
| October 21st, 2022 |
Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional) |
National Institutes of Health |
| October 21st, 2022 |
Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional) |
National Institutes of Health |
|
| March 10th, 2023 |
Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Neglected Tropical Diseases |
Centers for Disease Control and Prevention ERA |
| October 21st, 2022 |
Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| December 7th, 2024 |
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 3rd, 2023 |
Health Promotion and Disease Prevention Research Centers: 2023 Special Interest Project Competitive Supplement (SIPS) |
Centers for Disease Control and Prevention ERA |
| March 28th, 2023 |
The State Physical Activity and Nutrition Program (SPAN) |
Centers for Disease Control NCCDPHP |
| May 30th, 2023 |
WISEWOMAN: Well-Integrated Screening and Evaluation of WOMen Across the Nation |
Centers for Disease Control NCCDPHP |
| March 7th, 2023 |
A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes |
Centers for Disease Control NCCDPHP |
| February 14th, 2023 |
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 14th, 2023 |
A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes-Subject Matter Expertise, Training, and Technical Assistance |
Centers for Disease Control NCCDPHP |
| April 11th, 2023 |
Racial and Ethnic Approaches to Community Health (REACH) |
Centers for Disease Control NCCDPHP |
| March 21st, 2023 |
The High Obesity Program (HOP) |
Centers for Disease Control NCCDPHP |
| May 15th, 2023 |
National Organization for Chronic Disease Prevention and Health Promotion |
Centers for Disease Control NCCDPHP |
| June 1st, 2023 |
National Partnerships to Promote Cancer Surveillance Standards and Support Data Quality and Operations of National Program of Cancer Registries |
Centers for Disease Control NCCDPHP |
| May 23rd, 2023 |
The Innovative Cardiovascular Health Program |
Centers for Disease Control NCCDPHP |
| April 25th, 2023 |
The National Cardiovascular Health Program |
Centers for Disease Control NCCDPHP |
| February 14th, 2023 |
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 11th, 2023 |
Advancing Violence Epidemiology in Real-Time (AVERT) |
Centers for Disease Control NCIPC |
| November 29th, 2022 |
NICHD Global Network for Womens and Childrens Health Research: Research Units (UG1 Clinical Trial Optional) |
National Institutes of Health |
| November 29th, 2022 |
NICHD Global Network for Womens and Childrens Health Research: Data Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| March 20th, 2024 |
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) |
National Institutes of Health |
